CMS 135 - Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) Therapy for Left Ventricular Systolic Dysfunction (LVSD)
CMS135v5 (2017)
CMS135v6 (2018)
CMS135v7 (2019)
Description: Percentage of patients aged 18 years and older with a diagnosis of heart failure (HF) with a current or prior left ventricular ejection fraction (LVEF) < 40% who were prescribed ACE inhibitor or ARB therapy either within a 12 month period when seen in the outpatient setting OR at each hospital discharge.
Initial Patient Population: All patients aged 18 years and older with a diagnosis of heart failure.
Denominator: Equals Initial Population with a current or prior LVEF < 40%
Numerator: Patients who were prescribed ACE inhibitor or ARB therapy either within a 12 month period when seen in the outpatient setting OR at each hospital discharge
Inverse Measure: No
Clinical Instructions
Track all patients aged 18+ prescribed an ACE inhibitor or ARB therapy within a 12-month period of the diagnosis of heart failure with a current or prior left ventricular ejection fraction (LVEF) < 40%.
- Ensure patient has one of the following diagnoses:
- Moderate left ventricular systolic dysfunction (disorder) - SNOMED 981000124106
- Severe left ventricular systolic dysfunction (disorder) - SNOMED 991000124109
- Numerator will be populated with patients prescribed an ACE inhibitor or ARB therapy within the measurement period.
Evidence
Name | Value Set |
Allergy/Intolerance | 2.16.840.1.113883.3.526.3.1489 |
Communication: From Patient To Provider | 2.16.840.1.113883.3.526.3.1140 |
Diagnosis | 2.16.840.1.113883.3.526.3.1211 |
Diagnosis | 2.16.840.1.113883.3.526.3.376 |
Diagnosis | 2.16.840.1.113883.3.526.3.1212 |
Diagnosis | 2.16.840.1.113883.3.526.3.1091 |
Diagnosis | 2.16.840.1.113883.3.526.3.1090 |
Diagnosis | 2.16.840.1.113883.3.526.3.378 |
Diagnosis | 2.16.840.1.113883.3.526.3.1151 |
Diagnostic Study, Performed | 2.16.840.1.113883.3.526.3.1134 |
Encounter, Performed | 2.16.840.1.113883.3.464.1003.101.12.1014 |
Encounter, Performed | 2.16.840.1.113883.3.464.1003.101.12.1007 |
Encounter, Performed | 2.16.840.1.113883.3.464.1003.101.12.1016 |
Encounter, Performed | 2.16.840.1.113883.3.464.1003.101.12.1012 |
Encounter, Performed | 2.16.840.1.113883.3.464.1003.101.12.1001 |
Encounter, Performed | 2.16.840.1.113883.3.464.1003.101.12.1008 |
Encounter, Performed | 2.16.840.1.113883.3.526.3.1012 |
Medication, Active | 2.16.840.1.113883.3.526.3.1139 |
Medication, Not Ordered | 2.16.840.1.113883.3.526.3.1139 |
Medication, Order | 2.16.840.1.113883.3.526.3.1139 |
Patient Characteristic Ethnicity | 2.16.840.1.114222.4.11.837 |
Patient Characteristic Payer | 2.16.840.1.114222.4.11.3591 |
Patient Characteristic Race | 2.16.840.1.114222.4.11.836 |
Patient Characteristic Sex | 2.16.840.1.113762.1.4.1 |